The pandemic has meant extensive changes to all aspects of daily life, and that includes how clinical trials are conducted. COVID-19 has forced clinical trials to modernize and accommodate patients in new ways, including a shift to decentralized trials. At Yourway, we consider ourselves pioneers in decentralized and direct-to-patient trials. We’re helping to lead the charge toward a more patient-centric supply chain by providing fully integrated solutions that enable researchers and developers to bring promising therapies to market, while promoting the maintenance of patient populations by providing materials and care in a capacity convenient for them.